Teva has nine US Copaxone patents being litigated with NVS/MNTA as indicated below. All nine patents are related and have the same inventors. For reasons that are unclear, only seven of these nine patents are listed in the FDA’s Orange Book; these seven have an Orange-Book expiration date of 5/24/14.
(Teva attempted to have three additional Copaxone patents pertaining to molecular-weight markers [Nos. 6514938, 7074580, and 7163802] included in the litigation, but this request was denied by the Court.)
Following are the patent numbers of the nine litigated patents with links to their descriptions on the US PTO’s website.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.